HIV Flashcards
WHO Clinical Staging of HIV/AIDS for adults and adolescents with confirmed HIV Infection - Stage 1
Asymptomatic
Persistent generalized lymphadenopathy
WHO Clinical Staging of HIV/AIDS for adults and adolescents with confirmed HIV Infection - Stage 2
• Unexplained moderate weight loss(<10% of presumed or measured body weight)
• Recurrent respiratory tract infections (sinusitis, tonsillitis, otitis media and pharyngitis)
• Herpes Zoster
• Angular Cheilitis
• Recurrent oral ulceration
• Pruritic popular eruption
• Seborrhoeic dermatitis
• Fungal nail infections
WHO Clinical Staging of HIV/AIDS for adults and adolescents with confirmed HIV Infection - Stage 3
• Unexplained severe weight loss (>10% of presumed or measured body weight)
• Unexplained chronic Diarrhoea for longer than one month
• Unexplained persistent fever (above 37.5C intermittent or constant, for longer than one month)
• Persistent oral candidiasis
• Oral hairy leukoplakia
• Pulmonary TB
• Severe bacterial infections ( eg. Pneumonia, empyrean, pyomyositis, bone or joint infection, meningitis, bacteremia)
• Acute necrotizing ulcerative stomatitis, gingivitis or periodontitis
• Unexplained anemia (<8g/dl), neutropenia (<0.5 x 10^9 per liter) and/or chronic theombocytopenia (<50 x 10 ^9 per liter)
WHO Clinical Staging of HIV/AIDS for adults and adolescents with confirmed HIV Infection - Stage 4a
• HIV wasting syndrome
• Pneumocystis pneumonia
• Recurrent severe bacterial pneumonia
• Chronic herpes simplex infection ( orolabial, genital or anorectal of more than one month’s duration or visceral at any site)
• Oesophageal candidiasis (or candidiasis of trachea, bronchi or lungs)
• Extrapulmonary TB
• Kaposi sarcoma
• CMV infection (retinitis or infection of other organs)
• CNS Toxoplasmosis
WHO Clinical Staging of HIV/AIDS for adults and adolescents with confirmed HIV Infection - Stage 4b
• HIV encephalopathy
• Extrapulmonary cryptococcis including meningitis
• Disseminated non-tuberculous mycobacterial infection
• Chronic cryptosporidiosis
• Chronic isoporidiasis
• Disseminated Nicosia ( Extrapulmonary histoplasmosis or coccidiomycosis)
• Recurrent septicemia (including non-typhoidal Salmonella)
• Lymphoma (cerebral or B-cell non-Hodgkin)
• Invasive cervical carcinoma
• Atypical disseminated leishmaniasis
• HIV associated nephropathy or HIV associated cardiomyopathy
When does Western Blot show indeterminate results?
• Early HIV infection
• HIV-2 infection
• Influenza vaccine
• Autoimmune Disease
• Pregnancy
• recent tetanus toxoid administration.
When is HIV rapid antibody test done?
• Occupational exposure
• Pregnant women presenting in labor with no previous HIV testing
• Patients who are unlikely to return for results of HIV test
Conditions that require urgent ART
• Pregnancy
• AIDS - defining conditions, including HIV-associated dementia and AIDS - associated malignancies
• Acute opportunistic infections (OIs)
• Lower CD4 counts (e.g., <200 cells/mm3)
• HIV - associated Nephropathy (HIVAN)
• HIV/Hepatitis B virus co-infection
• HIV/Hepatitis C virus co-infection
What do you look for when monitoring efficacy of ARV’s?
- Weight gain
- Decrease or disappearance of symptoms
- Decrease in frequency and/or severity of OIs
- Increase in CD4+ count of an average of 100 cells per year
- Sustained suppression of HIV viral loads to undetectable levels
How is HIV trasmitted?
- Sexually
- Parenterally e.g. transfusion of infected blood, shared IV drug paraphernalia, needle stick injury with infected blood
- Vertically i.e. mother-to-child transmission (MTCT), which can occur during pregnancy, delivery or breastfeeding
What are the two main types of HIV and how do they cause disease
HIV - 1
HIV - 2
Either one can infect a host or both can infect a host.
How many groups of HIV 1 exist and what do they represent?
Four groups of HIV-1 exist and represent three separate transmission events from chimpanzees (M, N, and O), and one from gorillas (P)
HIV 1 Subgroups, Clades and Distribution
Group M is the cause of the global HIV pandemic; consists of nine clades: A–D, F–H, J, and K
Group N, O, and P are restricted to west Africa
HIV 1 Clade C and B areas
Clade C predominates in Africa and India
Clade B predominates in western Europe, the Americas, and Australia
Why is there marked diversity in HIV 1?
The marked genetic diversity of HIV-1 is a consequence of the error prone function of reverse transcriptase which results in a high mutation rate
What are the implications for the global distribution of the clades
The global distribution of the various clades has implications for vaccines development